基于SIRT1/SIRT3/FOXO1信号通路探讨染料木素减轻酒精性脂肪肝的作用机制OA
Exploring the mechanism by which genistein alleviates alcoholic fatty liver disease through affecting SIRT1/SIRT3/FOXO1 signaling pathway
目的 探讨染料木素是否通过调控 SIRT1/SIRT3/FOXO1 信号通路减轻酒精性脂肪肝(AFLD).方法 采用 100 μmol/L油酸联合 150 mmol/L 95%乙醇处理诱导HepG2 AFLD模型.实验设 16组,包括对照组、模型组、染料木素组、白藜芦醇组、SIRT1 基因沉默对照组/模型组/染料木素组/白藜芦醇组(C-shSIRT1/M-shSIRT1/G-shSIRT1/R-shSIRT1)、SIRT3 基因沉默对照组/模型组/染料木素组/白藜芦醇组(C-shSIRT3/M-shSIRT3/G-shSIRT3/R-shSIRT3)、SIRT1/SIRT3 双基因沉默对照组/模型组/染料木素组/白藜芦醇组(C-shSIRT1/3/M-shSIRT1/3/G-shSIRT1/3/R-shSIRT1/3).经油红O染色、甘油三酯(TG)、总胆固醇(TC)、游离脂肪酸(FFA)水平测定分析细胞脂肪变性,ELISA测定细胞内肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)和白介素-1β(IL-1β)水平.分别采用Western blot、免疫共沉淀(Co-IP)检测各实验组细胞中SIRT1、SIRT3 和FOXO1 蛋白表达水平与蛋白间的相互作用.结果 染料木素能显著改善AFLD模型细胞的脂质沉积和炎症反应(P<0.05).与对照组相比,模型组 SIRT1、SIRT3 和 FOXO1 蛋白表达水平均显著降低(P<0.01);与模型组相比,染料木素组SIRT1、SIRT3 和FOXO1 蛋白表达均表达水平显著增加(P<0.05).Co-IP结果显示SIRT1、SIRT3 与FOXO1 之间彼此存在相互作用.SIRT1 或SIRT3 基因沉默后染料木素均能显著改善细胞脂肪变性,但这两基因同时沉默后,染料木素的抗 AFLD 作用显著降低.与 C-shSIRT1 组比较,M-shSIRT1 组FOXO1 表达显著增高(P<0.01);与M-shSIRT1 组比较,G-shSIRT1 组FOXO1 表达显著降低(P<0.01).与C-shSIRT3 组比较,M-shSIRT3 组 FOXO1 表达显著降低(P<0.01);与 M-shSIRT3 组比较,G-shSIRT3 组FOXO1 表达显著增加(P<0.01).与C-shSIRT1/3 组比较,M-shSIRT1/3 组FOXO1 表达显著降低(P<0.01);M-shSIRT1/3 组与G-shSIRT1/3 组FOXO1 表达水平相似(P>0.05).结论 染料木素能够通过调控SIRT1/SIRT3/FOXO1 通路改善HepG2 AFLD细胞脂质代谢和抑制炎症反应,其中SIRT3/FOXO1 轴尤为关键.
Objective To investigate whether genistein alleviates alcoholic fatty liver disease(AFLD)by regulating sirtuin1(SIRT1)/sirtuin3(SIRT3)/forkhead box protein O1(FOXO1)signaling pathway.Methods A HepG2 AFLD model was induced using 100 μmol/L oleic acid combined with 150 mmol/L 95%ethanol.The experiment was divided into 16 groups,including control,model,genistein,and resveratrol groups,SIRT1 gene silencing control+model,genistein,and resveratrol groups(C-shSIRT1,M-shSIRT1,G-shSIRT1,and R-shSIRT1,respectively),SIRT3 gene silencing control+model,genistein,and resveratrol groups(C-shSIRT3,M-shSIRT3,G-shSIRT3,and R-shSIRT3,respectively),and SIRT1/SIRT3 dual gene silencing control+model,genistein,and resveratrol groups(C-shSIRT1/3,M-shSIRT1/3,G-shSIRT1/3,and R-shSIRT1/3,respectively).Cellular steatosis was analyzed through Oil Red O staining and measurements of triglyceride,total cholesterol,and free fatty acid levels.Intracellular levels of tumor necrosis factor-α and interleukins 6 and 1β were determined by enzyme-linked immunosorbent assay.Western blot was used to detect protein expression levels of SIRT1,SIRT3,and FOXO1,and their interactions were analyzed by co-immunoprecipitation.Results Genistein significantly reduced lipid deposition and inflammatory responses in HepG2 AFLD model cells(P<0.05).Compared with the control group,protein expression of SIRT1,SIRT3,and FOXO1 was significantly decreased in the model group(P<0.01).Compared with the model group,the genistein group showed significantly increased protein expression of SIRT1,SIRT3,and FOXO1(P<0.05).Co-immunoprecipitation result showed that SIRT1,SIRT3 and FOXO1 interacted.Genistein significantly reduced cellular steatosis after either SIRT1 or SIRT3 gene silencing,but its anti-AFLD effect was attenuated when both genes were simultaneously silenced.Compared with the C-shSIRT1 group,FOXO1 expression was significantly increased in the M-shSIRT1 group(P<0.01).Compared with the M-shSIRT1 group,FOXO1 expression was significantly decreased in the G-shSIRT1 group(P<0.01).Compared with the C-shSIRT3 group,FOXO1 expression was significantly decreased in the M-shSIRT3 group(P<0.01).Compared with the M-shSIRT3 group,FOXO1 expression was significantly increased in the G-shSIRT3 group(P<0.01).Compared with the C-shSIRT1/3 group,FOXO1 expression was significantly decreased in the M-shSIRT1/3 group(P<0.01);FOXO1 expression levels were similar between the M-shSIRT1/3 and G-shSIRT1/3 groups(P>0.05).Conclusions Genistein ameliorates lipid metabolism and suppresses inflammatory response in HepG2 AFLD cells by regulating SIRT1/SIRT3/FOXO1 signaling pathway,with the SIRT3/FOXO1 axis playing a particularly crucial role.
邹迎接;刘江丽;易旭;吴雪莉;王硕石;游绍伟
贵州中医药大学,贵阳 550005贵州中医药大学第二附属医院,贵阳 550003贵州中医药大学第二附属医院,贵阳 550003贵州中医药大学第二附属医院,贵阳 550003贵州中医药大学第二附属医院,贵阳 550003贵州中医药大学第二附属医院,贵阳 550003
医药卫生
酒精性脂肪肝染料木素HepG2细胞SIRT1/SIRT3/FOXO1信号通路
alcoholic fatty liver diseasegenisteinHepG2 cellsSIRT1/SIRT3/FOXO1 signaling pathway
《中国比较医学杂志》 2026 (3)
46-57,12
国家自然科学基金项目(82360881)贵州省科技厅基础研究计划(黔科合基础-ZK[2023]一般410).
评论